Nursing impact on the CAR-T cell landscape

Lancet Haematol. 2020 Mar;7(3):e192. doi: 10.1016/S2352-3026(20)30033-8.

Authors

Kathleen McDermott¹, Lauren Spendley²

Affiliations

¹ Cellular Therapies Program, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: [email protected].
² Cellular Therapies Program, Dana-Farber Cancer Institute, Boston, MA, USA.

PMID: 32109403
DOI: 10.1016/S2352-3026(20)30033-8

No abstract available

MeSH terms

Humans
Nursing / trends*
Receptors, Antigen, T-Cell / therapeutic use*

Substances

Receptors, Antigen, T-Cell